June 30, 2020 / 11:15 AM / 15 days ago

BRIEF-Humanigen - First Patient Infused In Zuma-19 Study, Being Conducted In Collaboration With Kite

June 30 (Reuters) - Gilead Sciences Inc:

* HUMANIGEN INC - FIRST PATIENT INFUSED IN ZUMA-19 STUDY, BEING CONDUCTED IN COLLABORATION WITH KITE, A GILEAD COMPANY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below